Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

PURPOSE: To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). PATIENTS AND METHODS: A phase II, open-label, multicenter study was conducted with single-agent clofarabine in pediatric patients with refractory or relapsed A...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jeha, Sima, Razzouk, Bassem, Rytting, Michael, Rheingold, Susan, Albano, Edythe, Kadota, Richard, Luchtman-Jones, Lori, Bomgaars, Lisa, Gaynon, Paul, Goldman, Stewart, Ritchey, Kim, Arceci, Robert, Altman, Arnold, Stine, Kimo, Steinherz, Laurel, Steinherz, Peter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744276/
https://ncbi.nlm.nih.gov/pubmed/19652076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.8706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak